Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells. (scientific article published in October 2007)

cites work (P2860)

Q52722381	A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts.
Q34744590	An inverse docking approach for identifying new potential anti-cancer targets.
Q28829206	Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells
Q33590593	Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors
Q46373886	Estrogen receptor-beta mediates the protective effects of aromatase induction in the MMTV-Her-2/neu x aromatase double transgenic mice
Q36794233	PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation
Q38994024	PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines
Q34047882	Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors
Q39109834	ΔNp63 expression in four carcinoma cell lines and the effect on radioresistance--a siRNA knockdown model

P2093	author name string	Cynthia Besch-Williford
		Salman M Hyder
		Yayun Liang
		Indira Benakanakere
P433	issue	4
P304	page(s)	777-784
P577	publication date	2007-10-01
P1433	published in	International Journal of Oncology	Q6051527
P1476	title	Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells
P478	volume	31

Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.